Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T15648 |
KDM5-C70
|
Histone Demethylase | Chromatin/Epigenetic |
KDM5-C70 是 KDM5-C49 的乙酯衍生物,是一种有效的细胞渗透性泛 KDM5 组蛋白去甲基化酶抑制剂。它在骨髓瘤细胞中具有抗增殖作用,可诱导全基因组 H3K4me3 水平升高。 | |||
T15649 |
KDM5-IN-1
|
Histone Demethylase | Chromatin/Epigenetic |
KDM5-IN-1 是一种有效的特异性 KDM5 抑制剂,IC50 为 15.1 nM。 | |||
T3576 |
CPI-455 analogue
CPI-455 analogue |
Others | Others |
CPI-455 analogue (CPI-455 analogue) 是 CPI-455 的结构类似物,CPI-455 是一种 KDM5 抑制剂。 | |||
T39989L |
JQKD82 trihydrochloride
|
Histone Demethylase | Chromatin/Epigenetic |
JQKD82 trihydrochloride 是一种细胞通透性和选择性 KDM5 抑制剂。JQKD82 trihydrochloride 增加 H3K4me3,可用于多发性骨髓瘤的研究。 | |||
T27723L |
KDM5-C49 HCl
KDM5-C49 HCl(1596348-16-1 Free base),KDOAM-20 hydrochloride |
Histone Demethylase | Chromatin/Epigenetic |
KDM5-C49 HCl (KDOAM-20 hydrochloride)KDM5-C49 HCl 是一种有效的和具有选择性的 去甲基化酶 KDM5抑制剂。KDM5-C49 HCl 是治疗癌症的候选化合物。 | |||
T3552 |
CPI-455
CPI-455 HCl |
Histone Demethylase | Chromatin/Epigenetic |
CPI-455 是一种特异性的泛KDM5抑制剂,对 KDM5A 的IC50为 10 nM。它介导 KDM5 抑制,提高 H3K4me3 的整体水平,有抗肿瘤作用。 | |||
T5484 |
GSK467
|
Histone Demethylase; Histone Methyltransferase | Chromatin/Epigenetic |
GSK467 是一种有效的、选择性的 KDM5 (JARID1) 抑制剂,Ki 值为10 nM。 | |||
T15650 |
KDM5A-IN-1
|
Histone Demethylase | Chromatin/Epigenetic |
KDM5A-IN-1 是一种可口服且具有高效性和选择性的泛组氨酸赖氨酸脱甲基酶 5 KDM5 抑制剂,抑制 KDM5A,KDM5B,KDM5C,IC50 值分别为 45 nM,56 nM 和 55 nM。KDM5A-IN-1 抑制 PC9 H3K4Me3,可用于研究癌症。 | |||
T39989 |
JQKD82
JADA82,PCK82,JQKD82 |
Histone Demethylase | Chromatin/Epigenetic |
JQKD82 是 KDM5 的选择性抑制剂,可增加 H3K4me3。 JQKD82可用于治疗多发性骨髓瘤的研究。 | |||
T27070 |
CPI-4203
CPI4203,CPI 4203 |
||
CPI-4203 is a selective inhibitor of KDM5 demethylases. | |||
T27723 |
KDM5-C49
KDM5C49 |
||
KDM5-C49 is a potent and selective inhibitor of KDM5, which regulates cell proliferation and stem cell self-renewal and differentiation. | |||
T73849 | KDM5-C49 hydrochloride | ||
KDM5-C49 (KDOAM-20) hydrochloride 是一种有效和选择性的KDM5去甲基化酶抑制剂,抑制KDM5A,KDM5B 和KDM5C 的IC50值分别为 40 nM,160 nM 和 100 nM。KDM5-C49 hydrochloride 可用于癌症的研究。 | |||
T11749 |
KDM4-IN-2
|
Glucokinase | Metabolism |
KDM4-IN-2 is a potent and selective KDM4/KDM5 dual inhibitor with Kis of 4 and 7 nM for KDM4A and KDM5B, respectively. | |||
T11751 |
KDOAM-25
|
Antibacterial | Microbiology/Virology |
KDOAM-25, a potent and highly selective inhibitor of histone lysine demethylases 5 (KDM5) with IC50 values of 71 nM for KDM5A, 19 nM for KDM5B, 69 nM for KDM5C, and 69 nM for KDM5D, enhances global H3K4 methylation at transcriptional start sites and reduces proliferation in multiple myeloma MM1S cells. | |||
T22299 | CPI-455 HCl | Histone Demethylase | Chromatin/Epigenetic |
CPI-455 is a specific KDM5 inhibitor with IC50 value of 10 ± 1 nM for full-length KDM5A in enzymatic assays, elevating global levels of H3K4 trimethylation (H3K4me3) and decreased the number of DTPs in multiple cancer cell line models treated with target | |||
T11750L |
KDOAM-25 trihydrochloride (2230731-99-2 free base)
KDOAM-25 trihydrochloride |
Others | Others |
KDOAM-25 trihydrochloride increases global H3K4 methylation at transcriptional start sites and impairs proliferation in multiple myeloma MM1S cells. KDOAM-25 trihydrochloride is a potent and highly selective histone lysine demethylases 5 (KDM5) inhibitor | |||
T11750 |
KDOAM-25 citrate
|
Others | Others |
KDOAM-25 citrate 是有效且具有高选择性的组蛋白赖氨酸脱甲基酶 5 (KDM5) 抑制剂,对 KDM5A,KDM5B,KDM5C,KDM5D 的IC50分别为 71 nM,19 nM,69 nM,69 nM。用KDOAM-25 citrate 处理的多发性骨髓瘤 MM1S 细胞显示转录起始位点的整体 H3K4 甲基化增加,增殖受损。 | |||
T62166 | KDOAM-25 trihydrochloride | ||
KDOAM-25 trihydrochloride 是一种有效的、高度选择性的组蛋白赖氨酸脱甲基酶 5 (KDM5) 抑制剂,能够作用于 KDM5A (IC50: 71 nM)、KDM5B (IC50: 19 nM)、KDM5C (IC50: 69 nM)、KDM5D (IC50: 69 nM)。KDOAM-25 trihydrochloride 能够提高转录起始位点的整体 H3K4 甲基化,可阻碍多发性骨髓瘤 MM1S 细胞的增殖。 |